Aphrodisiac Drug and Dental Health: A Systematic Review
Abstract
Aphrodisiac drugs, including both synthetic agents such as sildenafil and herbal formulations like ginseng, are widely used for enhancing sexual function. Emerging evidence suggests these agents may also impact oral and periodontal health, though the relationship remains underexplored. To systematically evaluate the effects of aphrodisiac drugs on dental and oral health outcomes. This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was performed to identify studies from 2000 to 2025. Inclusion criteria encompassed original studies involving aphrodisiac drugs with reported oral health outcomes. Reviews, animal studies, in vitro research, and clinical trials were all considered. Ten studies met the eligibility criteria. Sildenafil was associated with reduced alveolar bone loss and inflammation in preclinical models. Ginsenosides demonstrated strong anti-inflammatory, antimicrobial, and osteogenic activity. One clinical trial found red ginseng mouth rinse comparable to chlorhexidine in plaque control. Overall, ginseng-derived compounds showed promise in managing periodontitis and maintaining oral health. Both synthetic and herbal aphrodisiac agents exhibit potential oral health benefits, especially in periodontal therapy. Further clinical research is essential to confirm their safety, efficacy, and applicability…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.